Trending...
- Madison: A New Way to Get Your Collection Schedules from the Streets Division
- Breaking Barriers: La Crosse's First-Ever Boys Volleyball Program Serves Up Excitement!
- Office Calgary Inc, announces office expansion plans
Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care
NEWTON, Mass. - WisconsinEagle -- National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, today announced the launch of two interrelated public health campaigns focused on patient awareness and access to advanced biomarker testing and clinical trials.
"While continued investment and concerted drug development efforts are certainly needed, the precision medicine era has arrived for patients with brain tumors," said David Arons, president and chief executive officer of NBTS. "With the World Health Organization's two recent reclassifications of central nervous system tumors in 2016 and 2021, patients with brain tumors need more precise diagnoses. These recent advances in the understanding of the molecular characteristics of tumor types, as well as new drug approvals and encouraging results from recent clinical trials, call for a greater understanding of patient options from the point of diagnosis. We want to ensure that brain tumors undergo comprehensive biomarker analysis and that patients and their care partners better understand and have improved access to clinical trials and expanded access options that might be their best source of care. To achieve this result, the NBTS campaigns will inform patients, seek improved coverage from insurers, and work with providers."
More on Wisconsin Eagle
NBTS is launching the campaigns based on data on educational gaps in the brain tumor community gathered via a broad survey. Data collection analysis will inform future strategies, in addition to already planned educational and engagement activities.
The campaigns are being launched and developed with the generous support from Bayer, Danaher Foundation, and Servier Pharmaceuticals.
About the National Brain Tumor Society
Building on over 30 years of experience, the National Brain Tumor Society (NBTS) unrelentingly invests in, mobilizes, and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and caregivers. Our focus on defeating brain tumors and improving the quality of patients' lives is powered by our partnerships across science, healthcare, policy, and business sectors. We fund treatments-focused research and convene those most critical to curing brain tumors once and for all. Join us at BrainTumor.org.
"While continued investment and concerted drug development efforts are certainly needed, the precision medicine era has arrived for patients with brain tumors," said David Arons, president and chief executive officer of NBTS. "With the World Health Organization's two recent reclassifications of central nervous system tumors in 2016 and 2021, patients with brain tumors need more precise diagnoses. These recent advances in the understanding of the molecular characteristics of tumor types, as well as new drug approvals and encouraging results from recent clinical trials, call for a greater understanding of patient options from the point of diagnosis. We want to ensure that brain tumors undergo comprehensive biomarker analysis and that patients and their care partners better understand and have improved access to clinical trials and expanded access options that might be their best source of care. To achieve this result, the NBTS campaigns will inform patients, seek improved coverage from insurers, and work with providers."
More on Wisconsin Eagle
- Madison: Implements a 1% Reduction Across City Agencies
- Elevate your equipment with a new Cherry Master game machine
- Custom medals provide options for special recognition
- Northwestern Mutual kicks off construction phase of downtown north office building modernization project
- SafeBreak® Vascular FDA Cleared for All Vascular Access Lines on Patients Two Weeks of Age and Up
NBTS is launching the campaigns based on data on educational gaps in the brain tumor community gathered via a broad survey. Data collection analysis will inform future strategies, in addition to already planned educational and engagement activities.
The campaigns are being launched and developed with the generous support from Bayer, Danaher Foundation, and Servier Pharmaceuticals.
About the National Brain Tumor Society
Building on over 30 years of experience, the National Brain Tumor Society (NBTS) unrelentingly invests in, mobilizes, and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and caregivers. Our focus on defeating brain tumors and improving the quality of patients' lives is powered by our partnerships across science, healthcare, policy, and business sectors. We fund treatments-focused research and convene those most critical to curing brain tumors once and for all. Join us at BrainTumor.org.
Source: National Brain Tumor Society
0 Comments
Latest on Wisconsin Eagle
- Madison: Fall Leaves and Yard Waste Collection Begins Week of October 8, 2023
- Larry Hogan Joins Worldwide Speakers Group
- Pikmykid Hosts Webinar on Georgia School Safety Grant
- The Documented Culinary Journey of AI Influencer, Chef Jade
- American Garden Rose Selections™ Announces 2024 Winners
- Boutique Consulting Firm with Unique Project Leadership Offering is Now GSA Approved
- A. O. Smith to Hold Third Quarter Conference Call on October 26, 2023
- Robotics and Automation are Driving Demand for Upgraded Warehouse Management Systems concludes new report from the Mobile Robot Directory
- Doctors for Cannabis Regulation Rebrands as Doctors for Drug Policy Reform
- New data reveals 87% Australian adults have experienced a work-related musculoskeletal injury
- NEOM and Maysalward to strengthen young gaming talent with launch of NEOM Game Dev Challenge
- Jeezy, Sexyy Red, Plies, And $hyfromdatre Support The HBCU Community With A Special Concert For NC College Students In Winston-Salem, NC on Oct. 27th
- Global Luxury Value Exchange, Idoneus, Transitions to 100% IDON Transactions
- USA Green Card Celebrates the State Department's Historic Inclusion of the UK in the DV-2025 Green Card Lottery
- International Thermal Systems Revolutionizes Industrial Manufacturing with RollSeal Oven
- Do Grandparents Make Good Parents?
- Cleveland Broadband Selects Axiros' AXESS 5 ACS Software for Advanced Gigabit Internet Service
- Green Office Partner Ranks on the Inc. 5000 Annual List of the Fastest Growing Companies in America
- Office Calgary Inc, announces office expansion plans
- Madison: A New Way to Get Your Collection Schedules from the Streets Division